Next Article in Journal
Special Issue “Microbial Interactions in Soil”: Editorial
Previous Article in Journal
Metagenomic Sequencing of Positive Blood Culture Fluid for Accurate Bacterial and Fungal Species Identification: A Pilot Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Fungus Nosema ceranae and a Sublethal Dose of the Neonicotinoid Insecticide Thiamethoxam Differentially Affected the Health and Immunity of Africanized Honey Bees

by
Alvaro De la Mora
1,
Nuria Morfin
1,
José C. Tapia-Rivera
2,
José O. Macías-Macías
2,
José M. Tapia-González
2,
Francisca Contreras-Escareño
3,
Tatiana Petukhova
4 and
Ernesto Guzman-Novoa
1,*
1
School of Environmental Sciences, University of Guelph, Guelph, ON N1G2W1, Canada
2
Centro de Investigaciones en Abejas, CUSUR, Universidad de Guadalajara, Enrique Arreola Silva 883, Zapotlan el Grande 49000, Jalisco, Mexico
3
Departamento de Producción Agricola, CUCSUR, Universidad de Guadalajara, Independencia Nal. 161, Autlan 48900, Jalisco, Mexico
4
Department of Population Medicine, University of Guelph, Guelph, ON N1G2W1, Canada
*
Author to whom correspondence should be addressed.
Microorganisms 2023, 11(5), 1258; https://doi.org/10.3390/microorganisms11051258
Submission received: 30 March 2023 / Revised: 1 May 2023 / Accepted: 9 May 2023 / Published: 10 May 2023
(This article belongs to the Section Parasitology)

Abstract

:
Honey bees (Apis mellifera L.) are affected by different biotic and abiotic stressors, such as the fungus Nosema ceranae and neonicotinoid insecticides, that negatively impact their health. However, most studies so far conducted have focused on the effect of these stressors separately and in European honey bees. Therefore, this study was conducted to analyze the impact of both stressors, singly and in combination, on honey bees of African descent that have demonstrated resistance to parasites and pesticides. Africanized honey bees (AHBs, Apis mellifera scutellata Lepeletier) were inoculated with N. ceranae (1 × 105 spores/bee) and/or chronically exposed for 18 days to a sublethal dose of thiamethoxam (0.025 ng/bee) to evaluate their single and combined effects on food consumption, survivorship, N. ceranae infection, and immunity at the cellular and humoral levels. No significant effects by any of the stressors were found for food consumption. However, thiamethoxam was the main stressor associated to a significant decrease in AHB survivorship, whereas N. ceranae was the main stressor affecting their humoral immune response by upregulating the expression of the gene AmHym-1. Additionally, both stressors, separately and combined, significantly decreased the concentration of haemocytes in the haemolymph of the bees. These findings indicate that N. ceranae and thiamethoxam differentially affect the lifespan and immunity of AHBs and do not seem to have synergistic effects when AHBs are simultaneously exposed to both stressors.

1. Introduction

Honey bees (Apis mellifera L.) are the most important pollinators of agricultural crops and are valuable contributors to the pollination of wild plants [1]. This is why it is concerning that beekeepers in North America and other parts of the world have been experiencing an unusually high loss of honey bee colonies during the last decade [2,3]. The causes of these high colony mortality rates are most likely related to the interaction of multiple stressing factors. Two of the most common stressors honey bees are exposed to are the fungus Nosema ceranae and neonicotinoid insecticides [4].
Nosema ceranae is a spore-forming fungus of the Class Microsporidia that infects the midgut epithelial cells of adult honey bees [5], and that is now widely distributed in many countries [6,7,8,9]. Although the evidence is not conclusive, N. ceranae infection has been identified as one of the stressors that may be associated with colony losses in North America and parts of Europe [10,11,12]. The infection by N. ceranae negatively affects nutrient digestion and absorption, causing energetic stress in the bees [13,14,15]. Nosema ceranae infected bees have a reduced lifespan compared to non-infected bees [16,17,18]. Moreover, N. ceranae can affect metabolic and immune pathways [19], impacting innate defense mechanisms by apparently immunosuppressing its host [20,21,22].
Neonicotinoids are neurotoxic systemic insecticides that act as acetylcholine receptor agonists in the central nervous system of insects [23]. Among these insecticides, thiamethoxam is one of the most widely used worldwide and is commonly applied as seed treatment of corn, soybean, and sunflower [24]. Bees are repeatedly exposed to sublethal doses of neonicotinoids while frequently collecting nectar and/or pollen from plants grown from pesticide-treated seeds [25]. Although a few studies have found no deleterious effects of neonicotinoids on honey bee health at the colony level [26,27], sublethal exposure to neonicotinoids has been reported to affect learning and memory [28,29], disrupt foraging activities [30,31,32], cause immune changes [33,34], affect the development of hypopharyngeal glands [35], decrease survivorship, and activate detoxification mechanisms in honey bees [36,37].
Studies on the combined effects of N. ceranae and neonicotinoids have found synergistic effects on increased honey bee mortality [38,39,40], but no interactions on haemocyte counts, phenoloxidase activity [38], or detoxification mechanisms [39]. Thus, the interaction between sublethal exposure to neonicotinoids and N. ceranae infections seems to be complex, and most of these types of studies have been conducted using honey bees of European subspecies (EHBs). Honey bees of tropical origin, such as the so-called Africanized bees (AHBs, descendants of A. m. scutellata Lepeletier), have demonstrated resistance to parasites and viruses [41,42,43,44], and higher tolerance to several insecticides in comparison with EHBs [45,46]. Moreover, no studies have investigated the effect of N. ceranae infection and/or exposure to neonicotinoid insecticides on both, the cellular and humoral immune responses of honey bees of African descent. Therefore, the objective of this study was to assess the effect of chronic exposure to thiamethoxam and/or N. ceranae on survivorship, infection development, and immune responses of AHBs.

2. Materials and Methods

2.1. Ethical Statement

This study was conducted under the supervision of researchers of the Bee Research Center, University of Guadalajara, Zapotlan, JAL, Mexico, and the Honey Bee Research Centre, University of Guelph, Guelph, ON, Canada. No permits were required to conduct the study.

2.2. Sources of Honey Bees and Nosema Ceranae Spores

The honey bees used in this study were obtained from three colonies located at the Bee Research Center, University of Guadalajara, in Zapotlan, Jalisco, Mexico (19°43′31″ N, 103°27′41″ W). Their Africanized origin was corroborated by analyzing samples for mtDNA and morphometric type [47] at the Honey Bee Research Centre, University of Guelph, in Canada. Bees obtained from the three experimental colonies were equally represented in all treatment groups.
For spore source and extraction, forager bees were collected from a colony previously identified to have high infection levels of N. ceranae [48]. A survey previously conducted by our group to identify pathogens of honey bees in the study area detected only N. ceranae but no N. apis (unpublished data). The guts of 20–30 bees were dissected and macerated in ddH2O to extract and purify spores of the parasite as per McGowan et al. [49]. Briefly, the macerate was filtered and centrifuged at 800× g for 8 min three times. The resulting pellet was re-suspended in ddH2O and the spores of Nosema in the suspension were quantified with a haemocytometer [48]. The average of three counts was used to calculate the number of spores per µL in the suspension, which was used to obtain a final suspension of 1 × 105 spores/µL of ddH20 through serial dilutions. The identification of only N. ceranae was verified in several subsamples as per Hamiduzzaman et al. [50].

2.3. Thiamethoxam Dilutions

A field realistic concentration of thiamethoxam was calculated based on the knowledge that a honey bee consumes 25–39 mg of nectar per day [51] and that the concentration of neonicotinoids in nectar from canola-treated plants range between 0.001 and 0.009 ng/mg [52,53]. Thus, the amount of thiamethoxam that a bee could consume in a day would be between 0.025 and 0.351 ng, which is about 13 to 176 times lower than the 24 h LD50 (4.4 ng) for honey bees [54]. The lowest amount of this range (0.025 ng) was used to calculate a thiamethoxam concentration of 1 × 10−3 ng/µL of food, considering an average consumption of 25 µL of sucrose syrup per bee per day [28,55]. To prepare the working dilutions, 10 mg of thiamethoxam (Sigma Aldrich®, Oakville, ON, Canada) were diluted in 100 mL of ddH2O and subsequently serially diluted to 10 ng/mL.

2.4. Treatments

Newly emerged bees (<24 h) were obtained from frames with capped brood incubated in screened emerging cages (5 × 28 × 25 cm) at 35 °C and 60% RH overnight. A subsample of 30 randomly chosen workers was used to confirm that they were free of Nosema spores [48]. Thirty bees were randomly assigned to each of four treatments and were starved for 2 h before being treated. The treatments were 1 × 105 N. ceranae spores/bee (N), 1 × 10−3 ng/µL-thiamethoxam (T), 1 × 105 N. ceranae spores/bee + 1 × 10−3 ng/µL-thiamethoxam (NT), and the control (C) that was not exposed to thiamethoxam, or to N. ceranae, and only received 50% sucrose syrup. The N. ceranae dose (1 × 105 spores/bee) was chosen to ensure infection development in the inoculated bees as previously demonstrated [49].
For the two N. ceranae treatments (N and NT), 10 µL of the spore suspension (1 × 105 spores/µL of ddH20) were diluted in 90 µL of 50% sucrose syrup to obtain a suspension of 1 × 104 spores/µL. Each bee was fed individually with 10 µL of the treated syrup (1 × 105 spores per bee) using a micropipette (Eppendorf, Mississauga, ON, Canada). The bees of treatments C and N were fed with 50% sucrose syrup only, whereas those of treatments T and NT received the experimental sublethal dose of thiamethoxam in the syrup for 18 days to emulate field realistic conditions. To prepare the syrup with the desired concentration of the pesticide, 10 mL of thiamethoxam solution (10 ng/mL) were diluted in 90 mL of 50% sucrose syrup.
Bees were kept in sterilized hoarding cages (15 × 10 × 10 cm) inside an incubator at 35 °C and 60% RH for 18 days, because it is known that the life cycle of N. ceranae lasts five to seven days, so spores could replicate more than one cycle. The bees were provided with dH2O and 50% sucrose syrup (containing or not thiamethoxam) ad libitum in gravity feeders. The syrup was replaced every day, and consumption was calculated daily by weighing the feeders before and 24 h after placing them on the cages, using a balance (Denver Instruments S-403, Bohemia, NY, USA). To obtain the amount of syrup consumed per bee, data were adjusted for daily mortality by dividing the amount of syrup consumed by the number of live bees in the cage. Dead bees were counted and removed every day. After 18 days, the remaining live bees were collected and kept at −70 °C until further analysis. This experiment was replicated six times.

2.5. Nosema Ceranae Infectivity and Infection Intensity

For the two groups of bees treated with N. ceranae spores (N and NT) and the control (C), workers were individually dissected and microscopically analyzed to determine whether they had detectable N. ceranae spores [48] to obtain infectivity rates for the parasite. Then, the individual samples were pooled for spore counts to determine N. ceranae infection intensity [48]. No N. ceranae spores were detected in bees from treatment C. The sample size for these analyses varied between 36 and 90 bees per treatment, depending on the treatment.

2.6. Effect of Stressors on Cellular Immunity

The effect of N. ceranae infection and thiamethoxam exposure on cellular immunity was assessed by estimating the concentration of haemocytes in the haemolymph of experimental bees. Between six and twelve bees from each experimental group were randomly selected at the end of the experiment and before freezing them to collect a sample of 4 µL haemolymph from each of them. Briefly, each bee was pierced with an entomological pin between the second and third dorsal tergite and the sample of haemolymph was collected with a micropipette. The haemolymph was spread over a microscope slide and stained with Hema 3® (Fisher Health Care Protocol, Mississauga, ON, Canada). The number of haemocytes per µL of haemolymph of the sampled bees was obtained as per Koleoglu et al. [56], and six replicates of these assessments were conducted.

2.7. Effect of Stressors on Humoral Immunity

The effect of the two stressors on humoral immunity was evaluated by measuring the expression of the immune-related gene hymenoptaecin (AmHym-1, GB51223). Hymenoptaecin, the product of AmHym-1, is an antimicrobial peptide (AMP) [57] that has been widely used as a marker to evaluate humoral immunity in honey bees [58]. The extraction of RNA and gene expression analysis of the samples were conducted at the Honey Bee Research Centre, University of Guelph, in Canada. Total RNA was extracted from three bee abdomens pooled from each biological repetition using TRIzol® Reagent (Fisher Scientific, Mississauga, ON, Canada) as per the manufacturer’s instructions. The RNA concentration (ng/µL) and quality values (absorbance ratio, 260/280 nm = 1.8−2.0) were determined with a spectrophotometer (NanodropLite™, Thermo Scientific, Mississauga, ON, Canada).
cDNA was prepared using a RevertAid™ H Minus First Strand cDNA Synthesis Kit (Fermentas, Burlington ON, Canada) following the manufacturer’s instructions, with 2000 ng of RNA per sample. The cDNA was stored at −20 °C until used for gene expression analysis. The primers reported by Evans [59] were used for the target gene, whereas beta actin (β-actin, GB44311) was used as reference gene, and was amplified with the primers used by Di Prisco et al. [60].
The efficiencies of the target and reference genes were determined based on standard curves of known concentration using 10-fold serial dilutions (109−101 copies) of 300 bp synthetic gene fragments (gBlocks®; Integrated DNA Technologies, Coralville, IA, USA). The qRT-PCR was performed with a BioRad CFX96™ thermocycler (Bio-Rad Laboratories, Mississauga, ON, Canada) with PowerUp™ SYBR Master Mix (2X) (Thermo Fisher Scientific, Mississauga, ON, Canada). Reactions were conducted in 20 µL: 2 µL of template, 0.6 µL of each primer (300 nM), 10 µL of PowerUp™ SYBR Master Mix (2X), and 6.8 µL of nuclease free H2O. The cycling protocol consisted of one cycle at 50 °C for 2 min, one at 95 °C for 10 min, and then 40 cycles at 95 °C for 15 s, and 60 °C for 60 s.
The expression level of the target gene was normalized to the expression level of the reference gene using the 2−ΔΔ (Livak) method [61] with the control group as calibrator. The Bio-Rad CFX Manager® 3.1 software (Bio-Rad Laboratories, Mississauga, ON, Canada) was used to calculate the expression ratio.

2.8. Statistical Analyses

The data on sucrose syrup consumption was square root transformed before subjecting them to a one-way ANOVA as it did not comply with normality based on a Shapiro–Wilk test. The data on proportion of infected bees were analyzed using the Welch two sample test. The data on N. ceranae intensity were analyzed using the Wilcoxon test, as they could not be normalized. The data on number of haemocytes and AmHym-1 gene expression were tested with a Shapiro–Wilk test and due to lack of normality, were natural-log and log2 transformed, respectively, before being analyzed with a one-way ANOVA and Fisher LSD tests. The survivorship data were subjected to survival analysis using the Kaplan–Meier log rank test, and the curves were compared using the Holm correction for multiple comparisons. The above statistical analyses were performed using R 3.3.1 (Foundation for Statistical Computing, Vienna, Austria).

3. Results

3.1. Effect of Nosema Ceranae And/or Thiamethoxam on Food Consumption and Survivorship

The mean daily sucrose syrup consumption per bee was not significantly different between treatments (F3, 428 = 1.376, p= 0.250; Table 1). However, a significant reduction in the probability of bee survival was found for some treatments (X2 = 50.5, df = 3, p < 0.0001; Figure 1). Pairwise comparisons showed a significant decrease in the proportion of bees that survived between treatments C (0.37) and T (0.13; p < 0.001), and between treatments C and NT (0.21, p < 0.01). However, no significant differences in honey bee survival were observed between treatments C and N (0.36; p = 0.844), showing that the main stressor associated with a decrease in bee survivorship was thiamethoxam.

3.2. Effect of Thiamethoxam on Nosema Ceranae Infectivity and Infection Intensity

Thiamethoxam did not affect the infectivity of N. ceranae as the mean proportion of infected bees in treatment N was not significantly different from that of bees in treatment NT (t = −0.24, p = 0.8; Table 2). For infection intensity, the number of replicated N. ceranae spores after 18 days of inoculation in N and NT treated bees was 43 and 13 times higher than the initial inoculum, respectively. However, despite this large gap in the number of spores between treatments, there were no significant differences in spore counts between N and NT-treated bees (W = 1242, p = 0.47; Table 2).

3.3. Effect of Nosema Ceranae and/or Thiamethoxam on Cellular Immunity

Nosema ceranae infection, thiamethoxam exposure, or the combination of both stressors, significantly reduced the concentration of haemocytes in treated bees compared to the control (F3, 229 = 5.493, p < 0.001; Figure 2). Bees of treatment C had the highest haemocyte counts, whereas bees of treatment T showed the lowest haemocyte counts. However, except for the control, no significant differences were found in haemocyte concentration between the other treatment groups (p > 0.05).

3.4. Effect of Nosema Ceranae and/or Thiamethoxam on Humoral Immunity

Nosema ceranae significantly upregulated AmHym-1 in N and NT-treated bees relative to the control (2.48 log2 and 2.64 log2 fold up regulation, respectively) (F3, 11 = 6.15, p = 0.017; Figure 3). Thiamethoxam treated bees did not differ from the control in the expression of this gene. Therefore, N. ceranae was the only stressor associated with an over-expression of AmHym-1.

4. Discussion

Africanized honey bee health and immunity were differentially affected by both N. ceranae infection and sublethal thiamethoxam exposure. However, sucrose syrup consumption was not affected by any of the treatments. Other studies have also shown similar results in that N. ceranae alone or combined with neonicotinoid insecticides did not affect syrup consumption in experimental bees [15,62,63]. Conversely, Kessler et al. [64] showed that acute oral exposure to thiamethoxam (doses > 25 times higher than the one used in this study) increased the food consumption of treated bees. Thus, the differences between studies seem to be related to the dose used.
Results of this study showed that N. ceranae infection did not have a significant effect on AHB survivorship and that thiamethoxam was the main stressor associated with reduced bee survivorship. Our study is in line with findings of previous reports that have also shown a reduction in the lifespan of bees exposed to thiamethoxam at doses several times higher than the one used in this study [65], as well as in combination with N. ceranae infection [63,66,67]. However, Gregorc et al. [68] reported no effect of a single exposure of AHBs to thiamethoxam, with doses five to fifty times lower than the one used in this study, and found no effects of N. ceranae and no interaction between thiamethoxam and N. ceranae on honey bee survivorship. Thus, it appears that the effect of thiamethoxam on honey bee survivorship is related to the dose and time of exposure. We chronically fed the bees with the pesticide for 18 days, which was meant to emulate a realistic field situation.
The decreased survivorship of bees exposed to thiamethoxam in this study may be related to its cytotoxic effect on cells of the central nervous system and on epithelial cells of the bee’s midgut, possibly resulting in an increase in physiological, energetic, and nutritional stress [68,69]. Additionally, the impact of the pesticide on bee lifespan might be related to effects on the cellular immune responses of the exposed bees (see discussion below).
N. ceranae infections did not have a significant effect on honey bee survivorship despite the fact that the parasite multiplied more than a dozen times relative to the initial inoculum. This means that the bees were continuously exposed to higher levels of N. ceranae infections over time such as chronic exposure to thiamethoxam, but still had less impact on survivorship than the pesticide.
The absence of a significant effect of N. ceranae infection on honey bee survivorship in this study could be explained by the activation of humoral immune responses in the experimental bees, including the upregulation of AmHym-1 [70], for the production of AMPs to neutralize microsporidian infections. These results could also be explained by the relatively short duration of the experiment. The impact of N. ceranae infection on honey bee mortality is more apparent after three weeks of infection [15,17,18]. Additionally, it could have been that we used low-pathogenic variants of N. ceranae that might not significantly affect honey bee longevity [71].
The proportion of bees infected with N. ceranae spores did not differ between N and NT-treated bees. In both groups, the percentage of infected bees was below 50%. A similar percentage of infected bees (<60%) was also reported in workers of AHB colonies from Brazil [72]. However, other studies have reported infectivity rates of 100% in EHBs inoculated with similar or lower concentration of Nosema spores than the one used in this study [49,73]. Thus, it seems that AHBs might be more suited to resist the establishment of N. ceranae infection compared to EHBs. Nevertheless, further studies are warranted to confirm these results.
Nosema ceranae infection intensity at the end of the experiment did not differ significantly between bees of treatment N and bees of treatment NT. The absence of significant differences in spore counts between bees inoculated with N. ceranae only and bees that were also exposed to a thiamethoxam sublethal dose has been observed in other studies [63,66]. However, even when thiamethoxam did not show a significant effect on the number of replicated spores in the analysis of this study, the spore loads in bees from group NT were 3.3 times lower compared to those of bees from group N (1.3 vs. 4.4 million spores/bee). The lack of statistical significance between the two experimental groups was probably due to the large variation in infection levels within treatments, which is common for Nosema spp. infections in honey bees [49]. These results, even when not significant, suggest that thiamethoxam might inhibit the replication of N. ceranae in the bees’ midgut. The inhibitory effect on N. ceranae proliferation has been observed for thiamethoxam and other neonicotinoids such as imidacloprid, thiacloprid and fipronil that also decreased N. ceranae spore loads in honey bees [38,39,62,68], and in the stingless bee Melipona colimana [74]. It is possible that neonicotinoids have antifungal activity as has been documented for imidacloprid that reduced the multiplication of fungi in beetles [75]. Conversely, other studies have reported that neonicotinoid insecticide exposure, including thiamethoxam, increased the number of N. ceranae spores in honey bees [39,76,77]. The disagreement of the above studies could be due to factors such as experimental setups, type and dose of neonicotinoid used, time of exposure, disease resistance of the experimental bees used, and genetic variability of N. ceranae strains. These hypotheses to explain the above results require further investigation.
The number of N. ceranae replicated spores in the inoculated bees of this study was about three to four times lower than what has been reported for EHBs in similar experiments, using the same or lower concentration of Nosema spp. inoculum [49,73,78]. These results may again indicate higher resistance of AHBs to N. ceranae relative to EHBs as has been suggested by several authors. For example, N. ceranae has been infecting AHBs in Brazil for over 40 years, with no evidence of disease or damage to the colonies [7]. Additionally, Mendoza et al. [79] found that bees from AHB colonies had 20% lower spore counts compared to bees of EHB colonies managed under similar conditions, whereas Fleites-Ayil et al. [80] reported low N. ceranae infection levels in AHBs compared to those reported from EHB studies. All these studies suggest more resistance to nosema disease in AHBs. However, additional research is needed to support this speculation.
Haemocytes mediate cellular immunity in insects including honey bees, providing defense mechanisms against fungi, bacteria, parasites, and viruses [81,82]. Bees of treatments T, N, and NT showed a significant decrease in haemocyte counts after 18 days of treatment compared to the control, indicating cellular immune suppression by the two stressors. Consequently, it may be possible that cellular immune suppression could potentially increase the bees’ susceptibility to other pathogens.
Such as in this study, suppression of honey bee cellular immunity due to sublethal exposure to neonicotinoids has been documented previously. For example, Brandt et al. [33] observed a decrease in haemocyte concentration, encapsulation response, and melanization in honey bees exposed to sublethal doses of clothianidin, thiacloprid, and imidacloprid. Likewise, N. ceranae decreased the number of circulating haemocytes over time in stingless bees [74]. Conversely, other studies reported that sublethal doses of neonicotinoid insecticides, including thiamethoxam and clothianidin, did not affect haemocyte concentration or slightly increased haemocyte counts in the haemolymph of honey bees exposed to the pesticides for 10 or less days of treatment [38,83]. Thus, the effect of thiamethoxam on decreasing the number of haemocytes in the bees of this study could be related to the relatively long-time of exposure to the chemical. In other insects, the number of haemocytes tends to decrease sharply after two weeks [84]. In this study, haemocyte counts were determined 18 days after treatments. Therefore, the lower haemocyte concentration observed in N. ceranae infected bees may have occurred over several days during which haemocytes engulfed spores of the parasite [85], thus reducing the number of circulating haemocytes. Another evidence that supports this explanation of our results is that N. ceranae infection has been found to reduce the concentration of circulating haemocytes by decreasing the expression of the gene glucose dehydrogenase [20], which is involved in the encapsulation of fungal pathogens [86].
The results of this study showed that the combination of N. ceranae infection and thiamethoxam exposure decreased the concentration of haemocytes in the haemolymph of honey bees by about the same degree caused by either of the stressors alone, indicating that both stressors separately and combined affected the cellular immune responses of bees similarly, but showed no synergistic effects. In addition to the mechanisms mentioned above to explain how neonicotinoids and N. ceranae may affect the immune cellular responses of honey bees, it has been shown that both stressors alter the encapsulation mechanism of haemocytes [87], which could further explain these results. However, this is something that warrants further investigation.
AmHym-1 regulates the production of hymenoptaecin, which is an important AMP of the immune humoral response in insects, because it has strong antimicrobial activity against bacteria and fungi [40,82]. Nosema ceranae was the only stressor that affected the expression of AmHym-1 in our experimental bees. An increase in the expression of this immune-related gene suggests that the bees reacted to the fungal infection by producing hymenoptaecin as a defense against the microsporidium. Although previous studies have shown that N. ceranae may downregulate the expression of AmHym-1 in bees at an early stage of infection [20,21], this and other recent studies have demonstrated an overexpression of this gene in response to infections by N. ceranae at >seven days post inoculation [78,88]. It seems that it takes at least one N. ceranae reproductive cycle to activate the production of AMPs for host defense against the fungus. Another study that chronically exposed AHBs to sublethal doses of imidacloprid found that the pesticide downregulated AmHym-1 [67], but the researchers used doses 100 times higher than the one used in this study.
Experimental bees were exposed to the sublethal dose of thiamethoxam longer than they were to N. ceranae infections since it takes at least five days for the microsporidium to complete a life cycle. However, if the pesticide had been more harmful than Nosema infection to the bees because of longer initial exposure (first five days), we would have seen that impact for all parameters measured and not only for survivorship when analyzing the effect of the separate treatments (T vs. N). Thiamethoxam did not affect cellular immunity more than Nosema infections and did not significantly influence humoral immunity.

5. Conclusions

Thiamethoxam was the main stressor associated with a decrease in AHB survivorship, whereas N. ceranae was the main stressor affecting their humoral immune response by upregulating the expression of AmHym-1. Additionally, both stressors inhibited the cellular immune response of the bees by reducing the concentration of circulating haemocytes, although no synergistic effects were observed. The dose of thiamethoxam and the concentration of spores of N. ceranae used in the present study are realistic under field conditions, and both stressors were able to affect AHB health in different ways. Thus, further research is warranted to better understand the mechanisms by which these stressors affect AHB health and how bees respond to their detrimental effects.

Author Contributions

E.G.-N., J.O.M.-M., J.M.T.-G. and F.C.-E. were involved in project planning, administration, and supervision; A.D.l.M. and J.C.T.-R. carried out experiments and data collection; N.M. conducted molecular analysis. T.P. performed statistical analyses; N.M., E.G.-N., F.C.-E. and A.D.l.M. wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This study was partially funded by a Pinchin Fam. Grant to EG-N (Grant No. 2016030). The Mexican Council of Science and Technology (CONACYT) provided scholarships for A.D.l.M. and J.C.T-R.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study will be made available upon reasonable request from the corresponding author.

Acknowledgments

We thank Ricardo Rocha and Lorena Pinal for providing laboratory infrastructure. Ulises Nuño, Shaira Alvarado, Miriam Rangel, Sara Dino, and Ana K. Ramos assisted in different ways during experiments.

Conflicts of Interest

The authors declare that they have no conflict of interests.

References

  1. Klein, A.M.; Vaissiere, B.E.; Cane, J.H.; Steffan-Dewenter, I.; Cunningham, S.A.; Kremen, C.; Tscharntke, T. Importance of pollinators in changing landscapes for world crops. Proc. R. Soc. B Biol. Sci. 2006, 274, 303–313. [Google Scholar] [CrossRef] [PubMed]
  2. Guzman-Novoa, E. Colony collapse disorder and other threats to honey bees. In One Health Case Studies: Addressing Complex Problems in a Changing World; Susan, C., Cork, D.C., Hall, K.A., Eds.; 5m Publishing: Essex, UK, 2016; pp. 204–216. [Google Scholar]
  3. Gray, A.; Noureddine, A.; Arab, A.; Ballis, A.; Brusbardis, V.; Bugeja Douglas, A.; Cadahía, L.; Charrière, J.D.; Chlebo, R.; Coffey, M.F.; et al. Honey bee colony loss rates in 37 countries using the COLOSS survey for winter 2019–2020: The combined effects of operation size, migration and queen replacement. J. Apic. Res. 2022, 62, 204–210. [Google Scholar] [CrossRef]
  4. Goulson, D.; Nicholls, E.; Botías, C.; Rotheray, E.L. Bee declines driven by combined stress from parasites, pesticides, and lack of flowers. Science 2015, 347, 1255957. [Google Scholar] [CrossRef] [PubMed]
  5. García-Palencia, P.; Martín-Hernández, R.; González-Porto, A.V.; Marin, P.; Meana, A.; Higes, M. Natural infection by Nosema ceranae causes similar lesions as in experimentally infected caged-worker honey bees (Apis mellifera). J. Apic. Res. 2010, 49, 278–283. [Google Scholar] [CrossRef]
  6. Klee, J.; Besana, A.M.; Genersch, E.; Gisder, S.; Nanetti, A.; Tam, D.Q.; Chinh, T.X.; Puerta, F.; Ruz, J.M.; Kryger, P.; et al. Widespread dispersal of the microsporidian Nosema ceranae, an emergent pathogen of the western honey bee, Apis mellifera. J. Invertebr. Pathol. 2007, 96, 1–10. [Google Scholar] [CrossRef] [PubMed]
  7. Teixeira, E.W.; dos Santos, L.G.; Sattler, A.; Message, D.; Alves, M.L.T.M.F.; Martins, M.F.; Grassi-Sella, M.L.; Francoy, T.M. Nosema ceranae has been present in Brazil for more than three decades infecting Africanized honey bees. J. Invertebr. Pathol. 2013, 114, 250–254. [Google Scholar] [CrossRef]
  8. Guerrero-Molina, C.; Correa-Benítez, A.; Hamiduzzaman, M.M.; Guzman-Novoa, E. Nosema ceranae is an old resident of honey bee (Apis mellifera) colonies in Mexico, causing infection levels of one million spores per bee or higher during summer and fall. J. Invertebr. Pathol. 2016, 141, 38–40. [Google Scholar] [CrossRef]
  9. Martín-Hernández, R.; Bartolomé, C.; Chejanovsky, N.; Le Conte, Y.; Dalmon, A.; Dussaubat, C.; García-Palencia, P.; Meana, A.; Pinto, M.A.; Soroker, V.; et al. Nosema ceranae in Apis mellifera: A 12 years postdetection perspective. Environ. Microbiol. 2018, 20, 1302–1329. [Google Scholar] [CrossRef]
  10. Cox-Foster, D.L.; Conlan, S.; Holmes, E.C.; Palacios, G.; Evans, J.D.; Moran, N.A.; Quan, P.L.; Briese, T.; Hornig, M.; Geiser, D.M.; et al. A metagenomic survey of microbes in honey bee colony collapse disorder. Science 2007, 318, 283–287. [Google Scholar] [CrossRef]
  11. Higes, M.; Martín-Hernández, R.; Botías, C.; Bailón, E.G.; González-Porto, A.V.; Barrios, L.; del Nozal, M.J.; Bernal, J.L.; Jiménez, J.J.; Palencia, P.G.; et al. How natural infection by Nosema ceranae causes honeybee colony collapse. Environ. Microbiol. 2008, 10, 2659–2669. [Google Scholar] [CrossRef]
  12. Currie, R.W.; Pernal, S.F.; Guzman-Novoa, E. Honey bee colony losses in Canada. J. Apic. Res. 2010, 49, 104–106. [Google Scholar] [CrossRef]
  13. Mayack, C.; Naug, D. Parasitic infection leads to decline in hemolymph sugar levels in honeybee foragers. J. Insect Physiol. 2010, 56, 1572–1575. [Google Scholar] [CrossRef] [PubMed]
  14. Martín-Hernández, R.; Botías, C.; Barrios, L.; Martínez-Salvador, A.; Meana, A.; Mayack, C.; Higes, M. Comparison of the energetic stress associated with experimental Nosema ceranae and Nosema apis infection of honeybees (Apis mellifera). Parasitol. Res. 2011, 109, 605–612. [Google Scholar] [CrossRef]
  15. Aufauvre, J.; Misme-Aucouturier, B.; Viguès, B.; Texier, C.; Delbac, F.; Blot, N. Transcriptome analyses of the honeybee response to Nosema ceranae and insecticides. PLoS ONE 2014, 9, e91686. [Google Scholar] [CrossRef]
  16. Goblirsch, M.; Huang, Z.Y.; Spivak, M. Physiological and behavioral changes in honey bees (Apis mellifera) induced by Nosema ceranae infection. PLoS ONE 2013, 8, e58165. [Google Scholar] [CrossRef]
  17. Emsen, B.; De la Mora, A.; Lacey, B.; Eccles, L.; Kelly, P.G.; Medina-Flores, C.A.; Petukhova, T.; Morfin, N.; Guzman-Novoa, E. Seasonality of Nosema ceranae infections and their relationship with honey bee populations, food stores, and survivorship in a North American region. Vet. Sci. 2020, 7, 131. [Google Scholar] [CrossRef] [PubMed]
  18. Valizadeh, P.; Guzman-Novoa, E.; Goodwin, P.H. Effect of immune inducers on Nosema ceranae multiplication and their impact on honey bee (Apis mellifera L.) survivorship and behaviors. Insects 2020, 11, 572. [Google Scholar] [CrossRef] [PubMed]
  19. Badaoui, B.; Fougeroux, A.; Petit, F.; Anselmo, A.; Gorni, C.; Cucurachi, M.; Cersini, A.; Granato, A.; Cardeti, G.; Formato, G.; et al. RNA-sequence analysis of gene expression from honeybees (Apis mellifera) infected with Nosema ceranae. PLoS ONE 2017, 12, e0173438. [Google Scholar] [CrossRef] [PubMed]
  20. Antúnez, K.; Martín-Hernández, R.; Prieto, L.; Meana, A.; Zunino, P.; Higes, M. Immune suppression in the honey bee (Apis mellifera) following infection by Nosema ceranae (Microsporidia). Environ. Microbiol. 2009, 11, 2284–2290. [Google Scholar] [CrossRef]
  21. Chaimanee, V.; Chantawannakul, P.; Chen, Y.; Evans, J.D.; Pettis, J.S. Differential expression of immune genes of adult honey bee (Apis mellifera) after inoculated by Nosema ceranae. J. Insect Physiol. 2012, 58, 1090–1095. [Google Scholar] [CrossRef]
  22. Valizadeh, P.; Guzman-Novoa, E.; Petukhova, T.; Goodwin, P.H. Effect of feeding chitosan or peptidoglycan on Nosema ceranae infection and gene expression related to stress and the innate immune response of honey bees (Apis mellifera). J. Invertebr. Pathol. 2021, 185, 107671. [Google Scholar] [CrossRef] [PubMed]
  23. Jeschke, P.; Nauen, R. Thiamethoxam: A neonicotinoid precursor converted to clothianidin in insects and plants. In Synthesis and Chemistry of Agrochemicals VII; American Chemical Society: New York, NY, USA, 2007. [Google Scholar]
  24. Maienfisch, P.; Angst, M.; Brandl, F.; Fischer, W.; Hofer, D.; Kayser, H.; Kobel, W.; Rindlisbacher, A.; Senn, R.; Steinemann, A.; et al. Chemistry and biology of thiamethoxam: A second generation neonicotinoid. Pest Manag. Sci. 2001, 57, 906–913. [Google Scholar] [CrossRef]
  25. Sur, R.; Stork, A. Uptake, translocation and metabolism of imidacloprid in plants. Bull. Insectology 2003, 56, 35–40. [Google Scholar]
  26. Schmuck, R.; Schöning, R.; Stork, A.; Schramel, O. Risk posed to honeybees (Apis mellifera L., Hymenoptera) by an imidacloprid seed dressing of sunflowers. Pest Manag. Sci. 2001, 57, 225–238. [Google Scholar] [CrossRef] [PubMed]
  27. Cutler, G.C.; Scott-Dupree, C.D. Exposure to clothianidin seed-treated canola has no long-term impact on honey bees. J. Econ. Entomol. 2007, 100, 765–772. [Google Scholar] [CrossRef] [PubMed]
  28. Decourtye, A.; Lacassie, E.; Pham-Delegue, M.H. Learning performances of honey bees (Apis mellifera L.) are differentially affected by imidacloprid according to the season. Pest Manag. Sci. 2003, 59, 269–278. [Google Scholar] [CrossRef]
  29. Morfin, N.; Goodwin, P.H.; Guzman-Novoa, E. The combined effects of Varroa destructor parasitism and exposure to neonicotinoids affects honey bee (Apis mellifera L.) memory and gene expression. Biology 2020, 9, 237. [Google Scholar] [CrossRef]
  30. Bortolotti, L.; Montanari, R.; Marcelino, J.; Medrzycki, P.; Maini, S.; Porrini, C. Effects of sub-lethal imidacloprid doses on the homing rate and foraging activity of honey bees. Bull. Insectology 2003, 56, 63–68. [Google Scholar]
  31. Yang, E.C.; Chuang, Y.C.; Chen, Y.L.; Chang, L.H. Abnormal foraging behavior induced by sublethal dosage of imidacloprid in the honey bee (Hymenoptera: Apidae). J. Econ. Entomol. 2008, 101, 1743–1748. [Google Scholar] [CrossRef]
  32. Henry, M.; Beguin, M.; Requier, F.; Rollin, O.; Odoux, J.F.; Aupinel, P.; Aptel, J.; Tchmitchian, S.; Decourtye, A. A common pesticide decreases foraging success and survival in honey bees. Science 2012, 336, 348–350. [Google Scholar] [CrossRef]
  33. Brandt, A.; Gorenflo, A.; Siede, R.; Meixner, M.; Büchler, R. The neonicotinoids thiacloprid, imidacloprid, and clothianidin affect the immunocompetence of honey bees (Apis mellifera L.). J. Insect Physiol. 2016, 86, 40–47. [Google Scholar] [CrossRef] [PubMed]
  34. Annoscia, D.; Di Prisco, G.; Becchimanzi, A.; Caprio, E.; Frizzera, D.; Linguadoca, A.; Nazzi, F.; Pennacchio, F. Neonicotinoid clothianidin reduces honey bee immune response and contributes to Varroa mite proliferation. Nat. Commun. 2020, 11, 5887. [Google Scholar] [CrossRef] [PubMed]
  35. Hatjina, F.; Papaefthimiou, C.; Charistos, L.; Dogaroglu, T.; Bouga, M.; Emmanouil, C.; Arnold, G. Sublethal doses of imidacloprid decreased size of hypopharyngeal glands and respiratory rhythm of honeybees in vivo. Apidologie 2013, 44, 467–480. [Google Scholar] [CrossRef]
  36. Tarek, H.; Hamiduzzaman, M.M.; Morfin, N.; Guzman-Novoa, E. Sub-lethal doses of neonicotinoids and carbamate insecticides reduce the lifespan and alter the expression of immune, health and detoxification related genes in honey bees (Apis mellifera). Genet. Mol. Res. 2018, 17, gmr16039908. [Google Scholar] [CrossRef]
  37. Morfin, N.; Goodwin, P.H.; Guzman-Novoa, E. Interaction of field realistic doses of clothianidin and Varroa destructor parasitism on adult honey bee (Apis mellifera L.) health and neural gene expression, and antagonistic effects on differentially expressed genes. PLoS ONE 2020, 15, e0229030. [Google Scholar] [CrossRef] [PubMed]
  38. Alaux, C.; Brunet, J.L.; Dussaubat, C.; Mondet, F.; Tchamitchan, S.; Cousin, M.; Brillard, J.; Baldy, A.; Luc, P.; Belzunces, L.P.; et al. Interactions between Nosema microspores and a neonicotinoid weaken honeybees (Apis mellifera). Environ. Microbiol. 2010, 12, 774–782. [Google Scholar] [CrossRef]
  39. Vidau, C.; Diogon, M.; Aufauvre, J.; Fontbonne, R.; Viguès, B.; Brunet, J.L.; Texier, C.; Biron, D.G.; Blot, N.; El Alaoui, H.; et al. Exposure to sublethal doses of fipronil and thiacloprid highly increases mortality of honeybees previously infected by Nosema ceranae. PLoS ONE 2011, 6, e21550. [Google Scholar] [CrossRef]
  40. Doublet, V.; Labarussias, M.; Miranda, J.R.; Moritz, R.F.; Paxton, R.J. Bees under stress: Sublethal doses of a neonicotinoid pesticide and pathogens interact to elevate honey bee mortality across the life cycle. Environ. Microbiol. 2015, 17, 969–983. [Google Scholar] [CrossRef]
  41. Martin, S.J.; Medina, L.M. Africanized honeybees have unique tolerance to Varroa mites. Trends Parasitol. 2004, 20, 112–114. [Google Scholar] [CrossRef]
  42. Medina-Flores, C.A.; Guzman-Novoa, E.; Hamiduzzaman, M.M.; Aréchiga-Flores, C.F.; López-Carlos, M.A. Africanized honey bees (Apis mellifera) have low infestation levels of the mite Varroa destructor in different ecological regions in Mexico. Genet. Mol. Res. 2014, 13, 7282–7293. [Google Scholar] [CrossRef]
  43. Hamiduzzaman, M.M.; Guzman-Novoa, E.; Goodwin, P.H.; Reyes-Quintana, M.; Koleoglu, G.; Correa-Benítez, A.; Petukhova, T. Differential responses of Africanized and European honey bees (Apis mellifera) to viral replication following mechanical transmission or Varroa destructor parasitism. J. Invertebr. Pathol. 2015, 126, 12–20. [Google Scholar] [CrossRef] [PubMed]
  44. Ramos-Cuellar, A.K.; De la Mora, A.; Contreras-Escareño, F.; Morfin, N.; Tapia-González, J.M.; Macías-Macías, J.O.; Petukhova, T.; Correa-Benítez, A.; Guzman-Novoa, E. Genotype, but not climate, affects the resistance of honey bees (Apis mellifera) to viral infections and to the mite Varroa destructor. Vet. Sci. 2022, 9, 358. [Google Scholar] [CrossRef] [PubMed]
  45. Malaspina, O.; Stort, A.C. DDT tolerance of Africanized bees, Italian bees (Apis mellifera ligustica) and their F1 hybrids (Hymenoptera: Apidae). J. Kans. Entomol. 1983, 56, 74–79. [Google Scholar]
  46. Danka, R.G.; Rinderer, T.E.; Hellmich, R.I.; Collins, A.M. Comparative toxicities of four topically applied insecticides to Africanized and European honey bees (Hymenoptera: Apidae). J. Econ. Entomol. 1986, 79, 18–21. [Google Scholar] [CrossRef]
  47. Nielsen, D.I.; Ebert, P.R.; Hunt, G.J.; Guzman-Novoa, E.; Kinnee, S.A.; Page, R.E. Identification of Africanized honey bees (Hymenoptera: Apidae) incorporating morphometrics and an improved Polymerase Chain Reaction mitotyping procedure. Ann. Entomol. Soc. Am. 1999, 92, 167–174. [Google Scholar] [CrossRef]
  48. Fries, I.; Chauzat, M.P.; Chen, Y.P.; Doublet, V.; Genersch, E.; Gisder, S.; Higes, M.; McMahon, D.P.; Martín-Hernández, R.; Natsopoulou, M.; et al. Standard methods for Nosema research. J. Apic. Res. 2013, 52, 1–28. [Google Scholar] [CrossRef]
  49. McGowan, J.; De la Mora, A.; Goodwin, P.H.; Habash, M.; Hamiduzzaman, M.M.; Kelly, P.G.; Guzman-Novoa, E. Viability and infectivity of fresh and cryopreserved Nosema ceranae spores. J. Microbiol. Methods 2016, 131, 16–22. [Google Scholar] [CrossRef]
  50. Hamiduzzaman, M.M.; Guzman-Novoa, E.; Goodwin, P.G. A simple multiplex PCR assay to diagnose and quantify Nosema infections in honey bees (Apis mellifera). J. Invertebr. Pathol. 2010, 105, 151–155. [Google Scholar] [CrossRef]
  51. Winston, M.L. (Ed.) Development and nutrition. In The Biology of the Honey Bee; Harvard University Press: Cambridge, MA, USA, 1991; pp. 46–71. [Google Scholar]
  52. [EFSA] European Food Safety Authority. Statement on the findings in recent studies investigating sublethal effects in bees of some neonicotinoids in consideration of the uses currently authorised in Europe. EFSA J. 2012, 10, 2752. [Google Scholar]
  53. Pilling, E.; Campbell, P.; Coulson, M.; Ruddle, N.; Tornier, I. A four-year field program investigating long-term effects of repeated exposure of honey bee colonies to flowering crops treated with thiamethoxam. PLoS ONE 2013, 8, e77193. [Google Scholar] [CrossRef]
  54. Laurino, D.; Manino, A.; Patetta, A.; Porporato, M. Toxicity of neonicotinoid insecticides on different honey bee genotypes. Bull. Insectology 2013, 66, 119–126. [Google Scholar]
  55. Free, J.B.; Spencer-Booth, Y. Observations on the temperature regulation and food consumption of honeybees (Apis mellifera). J. Exp. Biol. 1958, 35, 930–937. [Google Scholar] [CrossRef]
  56. Koleoglu, G.; Goodwin, P.; Reyes-Quintana, M.; Hamiduzzaman, M.M.; Guzman-Novoa, E. Varroa destructor parasitism reduces hemocyte concentrations and prophenol oxidase gene expression in bees from two population. Parasitol. Res. 2018, 117, 1175–1183. [Google Scholar] [CrossRef] [PubMed]
  57. Doublet, V.; Poeschl, Y.; Gogol-Doring, A.; Alaux, C.; Annoscia, D.; Aurori, C.; Barribeau, S.M.; Bedoya-Reina, O.C.; Brown, M.J.; Bull, J.C.; et al. Unity in defence: Honeybee workers exhibit conserved molecular responses to diverse pathogens. BMC Genom. 2017, 18, 207. [Google Scholar] [CrossRef] [PubMed]
  58. Hinshaw, C.; Evans, K.C.; Rosa, C.; Lopez-Uribe, M.M. The role of pathogen dynamics and immune gene expression in the survival of feral honey bees. Front. Ecol. Evol. 2021, 8, 505. [Google Scholar] [CrossRef]
  59. Evans, J.D. Beepath: An ordered quantitative-PCR array for exploring honey bee immunity and disease. J. Invertebr. Pathol. 2006, 93, 135–139. [Google Scholar] [CrossRef]
  60. Di Prisco, G.; Cavaliere, V.; Annoscia, D.; Varricchio, P.; Caprio, E.; Nazzi, F.; Gargiulo, G.; Pennacchio, F. Neonicotinoid clothianidin adversely affects insect immunity and promotes replication of a viral pathogen in honey bees. Proc. Natl. Acad. Sci. USA 2013, 110, 18466–18471. [Google Scholar] [CrossRef]
  61. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  62. Retschnig, G.; Neumann, P.; Williams, G.R. Thiacloprid-Nosema ceranae interactions in honey bees: Host survivorship but not parasite reproduction is dependent on pesticide dose. J. Invertebr. Pathol. 2014, 118, 18–19. [Google Scholar] [CrossRef]
  63. Paris, L.; Peghaire, E.; Moné, A.; Diogon, M.; Debroas, D.; Delbac, F.; El Alaoui, H. Honeybee gut microbiota dysbiosis in pesticide/parasite co-exposures is mainly induced by Nosema ceranae. J. Invertebr. Pathol. 2020, 172, 107348. [Google Scholar] [CrossRef]
  64. Kessler, S.C.; Tiedeken, E.J.; Simcock, K.L.; Derveau, S.; Mitchell, J.; Softley, S.; Radcliffe, A.; Stout, J.C.; Wrigh, G.A. Bees prefer foods containing neonicotinoid pesticides. Nature 2015, 521, 74–76. [Google Scholar] [CrossRef] [PubMed]
  65. Domingues, C.E.C.; Abdalla, F.C.; Balsamo, P.J.; Pereira, B.V.R.; Hausen, M.A.; Costa, M.J.; Silva-Zacarin, E.C.M. Thiamethoxam and picoxistrobin reduce the survival and overload the hepato-nephrotic system of the Africanized honeybee. Chemosphere 2017, 186, 994–1005. [Google Scholar] [CrossRef] [PubMed]
  66. Liu, Z.; Li, S.; Li, H. Interactions between sublethal doses of thiamethoxam and Nosema ceranae in the honey bee, Apis mellifera. J. Apic. Res. 2021, 60, 717–725. [Google Scholar] [CrossRef]
  67. Balbuena, S.; Castelli, L.; Antúnez, K. Effect of chronic exposure to sublethal doses of imidacloprid and Nosema ceranae on immunity, gut microbiota, and survival of Africanized honey bees. Microb. Ecol. 2022, 85, 1485–1497. [Google Scholar] [CrossRef] [PubMed]
  68. Gregorc, A.; Silva-Zacarin, E.C.; Carvalho, S.M.; Kramberger, D.; Teixeira, E.W.; Malaspina, O. Effects of Nosema ceranae and thiamethoxam in Apis mellifera: A comparative study in Africanized and Carniolan honey bees. Chemosphere 2016, 147, 328–336. [Google Scholar] [CrossRef]
  69. Oliveira, R.A.; Roat, T.C.; Carvalho, S.M.; Malaspina, O. Side-effects of thiamethoxam on the brain and midgut of the Africanized honeybee Apis mellifera (Hymenopptera: Apidae). Environ. Toxicol. 2013, 10, 1122–1133. [Google Scholar]
  70. Lemaitre, B.; Hoffmann, J. The host defense of Drosophila melanogaster. Annu. Rev. Immunol. 2007, 25, 697–743. [Google Scholar] [CrossRef]
  71. Branchiccela, C.; Arredondo, D.; Higes, M.; Invernizzi, C.; Martín-Hernández, R.; Tomasco, I.; Zunino, P.; Antúnez, K. Characterization of Nosema ceranae genetic variants from different geographic origins. Microb. Ecol. 2016, 73, 978–987. [Google Scholar] [CrossRef]
  72. Chagas, D.B.; Monteiro, F.L.; da Barcelos, L.S.; Fruhauf, M.I.; Ribeiro, L.C.; de Lima, M.; de Hubner, S.O.; Fischer, G. Black queen cell virus and Nosema ceranae coinfection in Africanized honey bees from southern Brazil. Pesqui. Vet. Bras. 2021, 40, 892–897. [Google Scholar] [CrossRef]
  73. Forsgren, E.; Fries, I. Comparative virulence of Nosema ceranae and Nosema apis in individual European honey bees. Vet. Parasitol. 2010, 170, 212–217. [Google Scholar] [CrossRef]
  74. Macías-Macías, J.O.; Tapia-Rivera, J.C.; De la Mora, A.; Tapia-González, J.M.; Contreras-Escareño, F.; Petukhova, T.; Morfin, N.; Guzman-Novoa, E. Nosema ceranae causes cellular immunosuppression and interacts with thiamethoxam to increase mortality in the stingless bee Melipona colimana. Sci. Rep. 2020, 10, 17021. [Google Scholar] [CrossRef] [PubMed]
  75. Furlong, M.J.; Groden, E. Evaluation of synergistic interactions between the Colorado potato beetle (Coleoptera: Chrysomelidae) pathogen Beauveria bassiana and the insecticides imidacloprid and cyromazine. J. Econ. Entomol. 2001, 94, 344–356. [Google Scholar] [CrossRef] [PubMed]
  76. Pettis, J.S.; vanEngelsdorp, D.; Johnson, J.; Dively, G. Pesticide exposure in honey bees results in increased levels of the gut pathogen Nosema. Naturwissenschaften 2012, 99, 153–158. [Google Scholar] [CrossRef] [PubMed]
  77. Alburaki, M.; Chen, D.; Skinner, J.A.; Meikle, W.G.; Tarpy, D.R.; Adamczyk, J.; Stewart, S.D. Honey bee survival and pathogen prevalence: From the perspective of landscape and exposure to pesticides. Insects 2018, 9, 65. [Google Scholar] [CrossRef] [PubMed]
  78. Sinpoo, C.; Paxton, R.J.; Disayathanoowat, T.; Krongdang, S.; Chantawannakul, P. Impact of Nosema ceranae and Nosema apis on individual worker bees of the two host species (Apis cerana and Apis mellifera) and regulation of host immune response. J. Insect Physiol. 2018, 105, 1–8. [Google Scholar] [CrossRef]
  79. Mendoza, Y.; Antúnez, K.; Branchiccela, B.; Anido, M.; Santos, E.; Invernizzi, E. Nosema ceranae and RNA viruses in European and Africanized honeybee colonies (Apis mellifera) in Uruguay. Apidologie 2014, 45, 224–234. [Google Scholar] [CrossRef]
  80. Fleites-Ayil, F.A.; Quezada-Euán, J.J.G.; Medina-Medina, L. Onset of foraging and lifespan of Africanized honey bees (Apis mellifera) infected with different levels of Nosema ceranae spores in Neotropical Mexico. Apidologie 2018, 49, 781–788. [Google Scholar] [CrossRef]
  81. Negri, P.; Maggi, M.; Ramirez, L.; Szawarski, N.; De Feudis, L.; Lamattina, L.; Eguaras, M. Cellular immunity in Apis mellifera: Studying hemocytes brings light about bees skills to confront threats. Apidologie 2015, 47, 379–388. [Google Scholar] [CrossRef]
  82. Morfin, N.; Anguiano-Baez, R.; Guzman-Novoa, E. Honey bee (Apis mellifera) Immunity. Vet. Clin. N. Am. Food Anim. Pract. 2021, 37, 521–533. [Google Scholar] [CrossRef]
  83. Balsamo, P.J.; da Domingues, C.E.C.; da Silva-Zacarin, E.C.M.; Gregorc, A.; Irazusta, S.P.; Salla, R.F.; Costa, M.J.; Abdalla, F.C. Impact of sublethal doses of thiamethoxam and Nosema ceranae inoculation on the hepato-nephrocitic system in young Africanized Apis mellifera. J. Apic. Res. 2019, 59, 350–361. [Google Scholar] [CrossRef]
  84. Texier, C.; Vidau, C.; Viguès, B.; El Alaoui, H.; Delbac, F. Microsporidia: A model for minimal parasite–host interactions. Curr. Opin. Microbiol. 2010, 13, 443–449. [Google Scholar] [CrossRef] [PubMed]
  85. Gilliam, M.; Shimanuki, H. In vitro phagocytosis of Nosema apis spores by honey-bee hemocytes. J. Invertebr. Pathol. 1967, 9, 387–389. [Google Scholar] [CrossRef] [PubMed]
  86. Lovallo, N.C.; Cox-Foster, D.L. Alteration in FAD-glucose dehydrogenase activity and hemocyte behaviour contribute to initial disruption of Manduca sexta immune response to Cotesia congregata parasitoids. J. Insect Physiol. 1999, 45, 1037–1048. [Google Scholar] [CrossRef] [PubMed]
  87. Grassl, J.; Holt, S.; Cremen, N.; Peso, M.; Hahne, D.; Baer, B. Synergistic effects of pathogen and pesticide exposure on honey bee (Apis mellifera) survival and immunity. J. Invertebr. Pathol. 2018, 159, 78–86. [Google Scholar] [CrossRef] [PubMed]
  88. Schwarz, R.S.; Evans, J.D. Single and mixed-species trypanosome and microsporidia infections elicit distinct, ephemeral cellular and humoral immune responses in honey bees. Develop. Comp. Immunol. 2013, 40, 300–310. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Kaplan–Meier curves showing the survival probability of honey bees exposed to a sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup) and/or Nosema ceranae (1 × 105 spores per bee) for 18 consecutive days. Log rank and Holm correction for multiple comparisons were used to determine significant differences between curves, which are indicated by different literals.
Figure 1. Kaplan–Meier curves showing the survival probability of honey bees exposed to a sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup) and/or Nosema ceranae (1 × 105 spores per bee) for 18 consecutive days. Log rank and Holm correction for multiple comparisons were used to determine significant differences between curves, which are indicated by different literals.
Microorganisms 11 01258 g001
Figure 2. Mean number of haemocytes per µL of haemolymph of honey bees subjected to the treatments for 18 days: Control (C), Nosema ceranae (1 × 105 spores per bee; N), sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup; T), and N. ceranae + thiamethoxam (NT). Different literals indicate significant differences between treatments based on one-way ANOVA and Fisher LSD tests of natural log-transformed data. Figure shows untransformed data.
Figure 2. Mean number of haemocytes per µL of haemolymph of honey bees subjected to the treatments for 18 days: Control (C), Nosema ceranae (1 × 105 spores per bee; N), sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup; T), and N. ceranae + thiamethoxam (NT). Different literals indicate significant differences between treatments based on one-way ANOVA and Fisher LSD tests of natural log-transformed data. Figure shows untransformed data.
Microorganisms 11 01258 g002
Figure 3. AmHym-1 relative expression in honey bees subjected to the treatments for 18 days: Control (C), Nosema ceranae (1 × 105 spores per bee; N), sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup; T), N. ceranae + thiamethoxam (NT). AmHym-1 expression was calculated using the Livak 2−ΔΔCt method, with β-actin as reference gene and 0 ng as calibrator. Different literals indicate significant differences between treatments based on one-way ANOVA and Fisher LSD tests. Log2 transformed data are presented.
Figure 3. AmHym-1 relative expression in honey bees subjected to the treatments for 18 days: Control (C), Nosema ceranae (1 × 105 spores per bee; N), sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup; T), N. ceranae + thiamethoxam (NT). AmHym-1 expression was calculated using the Livak 2−ΔΔCt method, with β-actin as reference gene and 0 ng as calibrator. Different literals indicate significant differences between treatments based on one-way ANOVA and Fisher LSD tests. Log2 transformed data are presented.
Microorganisms 11 01258 g003
Table 1. Mean sucrose syrup consumption (µL ± SE) per honey bee/24 h during 18 days was subjected to the following treatments: Control (C), Nosema ceranae (1 × 105 spores per bee; N), sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup for 18 days; T), N. ceranae + thiamethoxam (NT).
Table 1. Mean sucrose syrup consumption (µL ± SE) per honey bee/24 h during 18 days was subjected to the following treatments: Control (C), Nosema ceranae (1 × 105 spores per bee; N), sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup for 18 days; T), N. ceranae + thiamethoxam (NT).
TreatmentsNMean ± SE
C10827.7 ± 1.3
N10824.6 ± 1.8
T10825.2 ± 1.8
NT10833.3 ± 6.1
F3, 428 = 1.376, p = 0.250
Table 2. Mean proportion (±SE) of honey bees infected with Nosema ceranae and spore counts at 18 days post-inoculation. Bees of both treatments were inoculated with 1 × 105 spores per bee. NT treated bees were also exposed to a sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup for 18 days).
Table 2. Mean proportion (±SE) of honey bees infected with Nosema ceranae and spore counts at 18 days post-inoculation. Bees of both treatments were inoculated with 1 × 105 spores per bee. NT treated bees were also exposed to a sublethal dose of thiamethoxam (1 × 10−3 ng/µL of syrup for 18 days).
TreatmentsProportion Infected Bees
(Mean ± Se)
No. Spores/Bee ± Se
N37.8 ± 10.094.38 × 106 ± 1.31 × 106
NT42.0 ± 13.81
t = −0.24, p = 0.8
1.35 × 106 ± 6.09 × 105
W = 1242, p = 0.47
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

De la Mora, A.; Morfin, N.; Tapia-Rivera, J.C.; Macías-Macías, J.O.; Tapia-González, J.M.; Contreras-Escareño, F.; Petukhova, T.; Guzman-Novoa, E. The Fungus Nosema ceranae and a Sublethal Dose of the Neonicotinoid Insecticide Thiamethoxam Differentially Affected the Health and Immunity of Africanized Honey Bees. Microorganisms 2023, 11, 1258. https://doi.org/10.3390/microorganisms11051258

AMA Style

De la Mora A, Morfin N, Tapia-Rivera JC, Macías-Macías JO, Tapia-González JM, Contreras-Escareño F, Petukhova T, Guzman-Novoa E. The Fungus Nosema ceranae and a Sublethal Dose of the Neonicotinoid Insecticide Thiamethoxam Differentially Affected the Health and Immunity of Africanized Honey Bees. Microorganisms. 2023; 11(5):1258. https://doi.org/10.3390/microorganisms11051258

Chicago/Turabian Style

De la Mora, Alvaro, Nuria Morfin, José C. Tapia-Rivera, José O. Macías-Macías, José M. Tapia-González, Francisca Contreras-Escareño, Tatiana Petukhova, and Ernesto Guzman-Novoa. 2023. "The Fungus Nosema ceranae and a Sublethal Dose of the Neonicotinoid Insecticide Thiamethoxam Differentially Affected the Health and Immunity of Africanized Honey Bees" Microorganisms 11, no. 5: 1258. https://doi.org/10.3390/microorganisms11051258

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop